Business UpdateApr 26, 2026, 05:33 AM
BDMD Details Business Combination, Regulatory Compliance
AI Summary
Baird Medical Investment Holdings Ltd (BDMD) filed its 20-F annual report, detailing its completed business combination with ExcelFin Acquisition Corp. The report outlines the corporate structure, regulatory compliance for its microwave ablation medical devices in China, and the ongoing risk related to the Holding Foreign Companies Accountable Act (HFCAA). It also notes the issuance of earnout shares and warrants as part of the business combination, with no cash or asset transfers or dividends paid in 2023-2025.
Key Highlights
- Business Combination with ExcelFin Acquisition Corp. completed in 2023-2024.
- Betters Medical Earnout Shares: 8,823,529 Ordinary Shares, vesting at $12.50 share price.
- Sponsor Earnout Shares: 1,350,000 Ordinary Shares, vesting at $12.50 share price.
- Public Warrants issued Oct 1, 2024, exercisable for Ordinary Shares at $11.50.
- Obtained multiple Class II/III medical device registration certificates and manufacturing licenses in China.
- Auditor is PCAOB-registered; HFCAA delisting risk remains.
- No cash/asset transfers or dividends paid in 2023, 2024, 2025.
Price Impact
More from BDMD